EcoR1 Capital, LLC Q3 2020 Filing
Filed November 16, 2020
Portfolio Value
$1.4T
Holdings
47
Report Date
Q3 2020
Filing Type
13F-HR
All Holdings (47 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 1 | XNCRXENCOR INC | 4,547,072 | $176.4B | 12.58% | |
| 2 | KURAKURA ONCOLOGY INC | 4,608,529 | $141.2B | 10.07% | |
| 3 | RLAYRELAY THERAPEUTICS INC | 3,200,649 | $136.3B | 9.72% | |
| 4 | PRTAPROTHENA CORP PLC | 9,426,640 | $94.2B | 6.71% | |
| 5 | MORFMORPHIC HLDG INC | 2,839,884 | $77.6B | 5.54% | |
| 6 | MRTXEURMIRATI THERAPEUTICS INC | 464,298 | $77.1B | 5.50% | |
| 7 | ORICORIC PHARMACEUTICALS INC | 2,642,218 | $66.1B | 4.71% | |
| 8 | RNAAVIDITY BIOSCIENCES INC | 2,103,950 | $59.2B | 4.22% | |
| 9 | ANABANAPTYSBIO INC | 3,223,324 | $47.5B | 3.39% | |
| 10 | —NEOLEUKIN THERAPEUTICS INC | 3,862,931 | $46.4B | 3.31% | |
| 11 | —AKOUOS INC | 1,975,984 | $45.2B | 3.22% | |
| 12 | ASMBASSEMBLY BIOSCIENCES INC | 2,566,182 | $42.2B | 3.01% | Call |
| 13 | NRIXNURIX THERAPEUTICS INC | 1,192,156 | $41.6B | 2.97% | |
| 14 | —APPLIED MOLECULAR TRANS INC | 1,150,000 | $36.6B | 2.61% | |
| 15 | BCELATRECA INC | 2,426,685 | $33.9B | 2.42% | |
| 16 | GONGERON CORP | 19,230,769 | $33.5B | 2.39% | |
| 17 | STROSUTRO BIOPHARMA INC | 3,113,617 | $31.3B | 2.23% | |
| 18 | RCUSARCUS BIOSCIENCES INC | 1,810,000 | $31.0B | 2.21% | |
| 19 | GOSS 5 06/01/27GOSSAMER BIO INC | 30,000,000 | $31.0B | 2.21% | |
| 20 | SURFUSDSURFACE ONCOLOGY INC | 3,333,177 | $23.0B | 1.64% | |
| 21 | —CYCLERION THERAPEUTICS INC | 2,742,276 | $16.7B | 1.19% | |
| 22 | GLYCEURGLYCOMIMETICS INC | 4,575,150 | $14.0B | 1.00% | Call |
| 23 | —ALLOVIR INC | 447,012 | $12.3B | 0.88% | |
| 24 | —BCTG ACQUISITION CORP | 800,000 | $8.3B | 0.59% | |
| 25 | —CONSTELLATION PHARMCETICLS I | 400,000 | $8.1B | 0.58% | Call |
| 26 | —LIFESCI ACQUISITION CORP | 630,505 | $7.8B | 0.56% | |
| 27 | NVLSEURALPINE IMMUNE SCIENCES INC | 741,290 | $6.5B | 0.46% | |
| 28 | 5E7ITEOS THERAPEUTICS INC | 260,000 | $6.4B | 0.46% | |
| 29 | —DEERFIELD HEALTHCARE TECH AC | 500,000 | $5.3B | 0.38% | |
| 30 | —PANACEA ACQUISITION CORP | 390,000 | $4.7B | 0.33% | |
| 31 | IRWDIRONWOOD PHARMACEUTICALS INC | 500,000 | $4.5B | 0.32% | Call |
| 32 | —HEALTH SCIENCES ACQ CORP 2 | 400,000 | $4.4B | 0.31% | |
| 33 | DYNDYNE THERAPEUTICS INC | 215,000 | $4.3B | 0.31% | |
| 34 | ACRSACLARIS THERAPEUTICS INC | 1,531,312 | $3.9B | 0.28% | |
| 35 | —FS DEV CORP | 350,000 | $3.9B | 0.28% | |
| 36 | —METACRINE INC | 333,332 | $3.4B | 0.24% | |
| 37 | KYMRKYMERA THERAPEUTICS INC | 100,000 | $3.2B | 0.23% | |
| 38 | RPRXROYALTY PHARMA PLC | 50,000 | $2.1B | 0.15% | |
| 39 | —FIVE PRIME THERAPEUTICS INC | 379,945 | $1.8B | 0.13% | |
| 40 | —EXICURE INC | 1,017,801 | $1.8B | 0.13% | |
| 41 | PMVPPMV PHARMACEUTICALS INC | 50,000 | $1.8B | 0.13% | |
| 42 | RPTXREPARE THERAPEUTICS INC | 50,000 | $1.5B | 0.11% | |
| 43 | MGTXMEIRAGTX HLDGS PLC | 94,819 | $1.3B | 0.09% | |
| 44 | ICPTUSDINTERCEPT PHARMACEUTICALS IN | 25,300 | $1.0B | 0.07% | Call |
| 45 | —UNITY BIOTECHNOLOGY INC | 296,000 | $1.0B | 0.07% | |
| 46 | XOMAXOMA CORP DEL | 50,809 | $957.0M | 0.07% | |
| 47 | YB4PSAVARA INC | 56,500 | $62.0M | 0.00% |